S&P 500   2,966.15 (-0.14%)
DOW   26,787.36 (-0.11%)
QQQ   191.09 (-0.01%)
AAPL   235.87 (-0.14%)
FB   183.28 (-0.49%)
MSFT   139.55 (-0.09%)
AMZN   1,736.43 (+0.26%)
CGC   18.84 (-3.04%)
BABA   171.21 (-1.00%)
GE   8.72 (-1.02%)
TSLA   256.96 (+3.66%)
F   8.82 (+0.46%)
ACB   3.52 (-4.61%)
NFLX   285.53 (+0.92%)
GILD   64.51 (+0.81%)
S&P 500   2,966.15 (-0.14%)
DOW   26,787.36 (-0.11%)
QQQ   191.09 (-0.01%)
AAPL   235.87 (-0.14%)
FB   183.28 (-0.49%)
MSFT   139.55 (-0.09%)
AMZN   1,736.43 (+0.26%)
CGC   18.84 (-3.04%)
BABA   171.21 (-1.00%)
GE   8.72 (-1.02%)
TSLA   256.96 (+3.66%)
F   8.82 (+0.46%)
ACB   3.52 (-4.61%)
NFLX   285.53 (+0.92%)
GILD   64.51 (+0.81%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 UniqureThe MedicinesAmicus TherapeuticsReata PharmaceuticalsArrowhead Pharmaceuticals
SymbolNASDAQ:QURENASDAQ:MDCONASDAQ:FOLDNASDAQ:RETANASDAQ:ARWR
Price Information
Current Price$41.90$52.22$7.94$100.79$33.00
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$76.92$73.33$18.93$141.33$36.70
% Upside from Price Target83.59% upside40.43% upside138.40% upside40.23% upside11.21% upside
Trade Information
Market Cap$1.62 billion$4.15 billion$1.94 billion$2.96 billion$3.15 billion
Beta0.840.911.572.41.48
Average Volume567,9082,093,1934,657,011315,8841,307,449
Sales & Book Value
Annual Revenue$11.28 million$6.14 million$91.25 million$53.59 million$16.14 million
Price / Sales140.60674.8622.1656.61193.85
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$4.82 per share($0.30) per share$1.81 per share$0.51 per share$1.08 per share
Price / Book8.69-174.074.39197.6330.56
Profitability
Net Income$-83,300,000.00$-123,160,000.00$-348,990,000.00$-80,550,000.00$-54,450,000.00
EPS($2.34)($2.91)($1.33)($2.87)($0.65)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-1,232.30%N/A-336.41%-410.38%33.28%
Return on Equity (ROE)-61.67%N/A-66.79%-3,282.73%26.27%
Return on Assets (ROA)-38.29%-24.68%-36.42%-35.30%16.20%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.51%21.45%0.31%N/AN/A
Current Ratio8.07%5.97%7.09%4.24%2.81%
Quick Ratio8.07%5.97%6.97%4.24%2.81%
Ownership Information
Institutional Ownership Percentage69.91%N/AN/A58.51%71.98%
Insider Ownership Percentage2.91%8.41%2.50%34.40%4.80%
Miscellaneous
Employees21262508123116
Shares Outstanding37.85 million79.35 million254.63 million30.10 million94.81 million
Next Earnings Date11/5/2019 (Estimated)11/14/2019 (Estimated)11/4/2019 (Estimated)11/6/2019 (Estimated)12/10/2019 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable
 UniqureThe MedicinesAmicus TherapeuticsReata PharmaceuticalsArrowhead Pharmaceuticals

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel